1. Home
  2. VERO vs CPHI Comparison

VERO vs CPHI Comparison

Compare VERO & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERO
  • CPHI
  • Stock Information
  • Founded
  • VERO N/A
  • CPHI N/A
  • Country
  • VERO Canada
  • CPHI China
  • Employees
  • VERO N/A
  • CPHI N/A
  • Industry
  • VERO Medical/Dental Instruments
  • CPHI Biotechnology: Pharmaceutical Preparations
  • Sector
  • VERO Health Care
  • CPHI Health Care
  • Exchange
  • VERO Nasdaq
  • CPHI Nasdaq
  • Market Cap
  • VERO 4.3M
  • CPHI 4.7M
  • IPO Year
  • VERO N/A
  • CPHI N/A
  • Fundamental
  • Price
  • VERO $2.32
  • CPHI $1.95
  • Analyst Decision
  • VERO
  • CPHI
  • Analyst Count
  • VERO 0
  • CPHI 0
  • Target Price
  • VERO N/A
  • CPHI N/A
  • AVG Volume (30 Days)
  • VERO 55.4K
  • CPHI 26.1K
  • Earning Date
  • VERO 11-13-2025
  • CPHI 11-12-2025
  • Dividend Yield
  • VERO N/A
  • CPHI N/A
  • EPS Growth
  • VERO N/A
  • CPHI N/A
  • EPS
  • VERO N/A
  • CPHI N/A
  • Revenue
  • VERO $60,107,000.00
  • CPHI $4,396,201.00
  • Revenue This Year
  • VERO N/A
  • CPHI N/A
  • Revenue Next Year
  • VERO $7.51
  • CPHI N/A
  • P/E Ratio
  • VERO N/A
  • CPHI N/A
  • Revenue Growth
  • VERO N/A
  • CPHI N/A
  • 52 Week Low
  • VERO $2.10
  • CPHI $1.20
  • 52 Week High
  • VERO $14.50
  • CPHI $3.35
  • Technical
  • Relative Strength Index (RSI)
  • VERO 46.51
  • CPHI 60.72
  • Support Level
  • VERO $2.26
  • CPHI $1.85
  • Resistance Level
  • VERO $2.65
  • CPHI $1.97
  • Average True Range (ATR)
  • VERO 0.10
  • CPHI 0.11
  • MACD
  • VERO 0.00
  • CPHI -0.01
  • Stochastic Oscillator
  • VERO 13.98
  • CPHI 78.00

About VERO Venus Concept Inc.

Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

Share on Social Networks: